Welcome to the ENTELLIGENCE Young Investigator Program

The ENTELLIGENCE Young Investigator Program is a US-based research program consistent with Actelion Pharmaceutical US, Inc.’s commitment to basic science, translational, and clinical research in the area of pulmonary vascular disease.

Young investigators at universities and research institutes in the United States and Canada with innovative projects and promising careers in pulmonary vascular disease have been supported by the ENTELLIGENCE program since 2005.

Individual grants of up to $100,000 are provided to qualified investigators to conduct research on the basic mechanisms and/or vascular biology of pulmonary vascular disease via a 12-month mentored grant. Grants are awarded by the ENTELLIGENCE Steering Committee and based on scientific merit, originality, feasibility, and applicability to the diagnosis and treatment of pulmonary hypertension.

The application process is simple:

1. Submit a Letter of Intent (LOI) proposal with an introduction, background, hypothesis and objectives, and specific aims
2. Have a mentor
3. If the LOI is selected, submit a full grant